Brookfield still pursuing Grifols deal, Bloomberg reports
EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...
Grifols falls on report Brookfield delays offer on funding issues
Grifols (NASDAQ:GRFS) dropped 3% after a report that Brookfield (BAM) is delaying a takeover bid due to issues raising money ...
New Atlas9d
World-first treatment to prevent long-term eye damage from mustard gas
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to ...
pharmaphorum6d
Could Spain’s Grifols be heading for de-listing?
The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...
Grifols receives FDA approval to treat surgical bleeding with FS solution
Grifols (GRFS) announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received ...
Grifols (NASDAQ:GRFS) Raised to Strong-Buy at Berenberg Bank
Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...
Morningstar2d
Grifols SA ADR GRFS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Yahoo Finance6d
Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations ...
1 man dead, 1 in custody after plasma center shooting, witnesses say shooter warned them
Police were called to the scene about 3 p.m. A man was pronounced dead and another was in custody, officials said.